Cargando…

P1252: THE ROLE OF PALMITOLEIC ACID IN REGULATING INTESTINAL FLORA TO IMPROVE ACUTE GRAFT-VERSUS-HOST DISEASE AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales:	Zhu, Haojie, Xu, Jingjing, Ye, Chenjing, Kong, Hui, Huang, Wenwen, Hu, Jianda, Yang, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431146/ http://dx.doi.org/10.1097/01.HS9.0000971896.56079.75

Ejemplares similares

Exploration of the relationship between intestinal flora changes and gut acute graft-versus-host disease after hematopoietic stem cell transplantation
por: Song, Aiyun, et al.
Publicado: (2021)

P1258: A CO-REACTIVATION MODEL OF DOUBLE-STRANDED DNA VIRUS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WAS CONSTRUCTED TO PREDICT THE MORTALITY AFTER TRANSPLANTATION
por: Ren, Jinhua, et al.
Publicado: (2023)

P1272: DEFIBROTIDE IMPACT ON THE ACUTE GRAFT-VERSUS-HOST DISEASE INCIDENCE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.
por: Squillaci, Domenica, et al.
Publicado: (2023)

P1510: INCIDENCE AND RISK FACTORS OF ACTIVE CARBAPENEM-RESISTANT ENTEROBACTERIACEAE SURVEILLANCE FOR PATIENTS ADMITTED TO HEMATOLOGY DEPARTMENT: A PROPENSITY SCORE MATCHING STUDY.
por: Chen, Shaozhen, et al.
Publicado: (2023)

P1252: PREDICTING THE RESPONSE OF DLBCL CELLS TO BH3-MIMETICS USING SYSTEMS BIOLOGY
por: Cloete, I., et al.
Publicado: (2022)

P1548: CMVR AND BSI ALONE AREN’T POOR PROGNOSIS RISK FACTORS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, BUT THEIR COMBINATION IS
por: Ren, Jinhua, et al.
Publicado: (2023)

P1561: HBSAG-POSITIVE PATIENTS WITH CO-REACTIVATION OF CYTOMEGALOVIRUS AND EPSTEIN-BARR VIRUSES AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION ASSOCIATED WITH POOR SURVIVAL
por: Ren, Jinhua, et al.
Publicado: (2023)

Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease
por: van Lier, Yannouck F., et al.
Publicado: (2023)

Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation
por: Lorenz, Fryderyk, et al.
Publicado: (2015)

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEUKEMIA ADVANTAGE IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER HAPLO-IDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE
por: Shimoni, A., et al.
Publicado: (2022)

Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
por: Kim, Dongsub, et al.
Publicado: (2018)

Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
por: Pereira, Andréa Z, et al.
Publicado: (2020)

Palmitoleate attenuates diet induced insulin resistance and hepatic inflammation independently of PPAR-α
por: Souza, Camila O, et al.
Publicado: (2014)

P1321: INCIDENCE AND IMPACT OF GRAFT-VERSUS-HOST DISEASE (GVHD) IN PATIENTS OVER 60 YEARS OF AGE UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT). RETROSPECTIVE EXPERIENCE OF TWO SPANISH CENTERS
por: Baile, M., et al.
Publicado: (2022)

Sinunasal ultrastructure of the transplant hematopoietic stem cell and chronic graft-versus-host disease with rhinosinusitis
por: Ortiz, Erica, et al.
Publicado: (2013)

Immune Reconstitution and Graft-Versus-Host Reactions in Rat Models of Allogeneic Hematopoietic Cell Transplantation
por: Zinöcker, Severin, et al.
Publicado: (2012)

Ultrasonographic evaluation of gastrointestinal graft‐versus‐host disease after hematopoietic stem cell transplantation
por: Nishida, Mutsumi, et al.
Publicado: (2015)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Nassar, Amr, et al.
Publicado: (2014)

Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review
por: Villarreal, Cesar Daniel Villarreal, et al.
Publicado: (2016)

Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation
por: Lee, Catherine, et al.
Publicado: (2018)

Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation
por: Simonetta, Federico, et al.
Publicado: (2017)

Sclerodermatous Graft-Versus-Host Disease: A Rare Sequela of Hematopoietic Stem Cell Transplantation
por: Jabin, Mohamad, et al.
Publicado: (2023)

P1308: RUXOLITINIB AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN APLASTIC ANEMIA PATIENTS
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

Personal dose-equivalent conversion coefficients for 1252 radionuclides
por: Otto, Thomas
Publicado: (2016)

Graft conditioning with fluticasone propionate reduces graft‐versus‐host disease upon allogeneic hematopoietic cell transplantation in mice
por: Varady, Erika S, et al.
Publicado: (2023)

Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies
por: Saldi, Simonetta, et al.
Publicado: (2022)

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

Muscle Cramps and Neuropathies in Patients with Allogeneic Hematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Kraus, Peter D., et al.
Publicado: (2012)

Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation
por: Petersdorf, Effie W.
Publicado: (2017)

Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation
por: Fatobene, Giancarlo, et al.
Publicado: (2019)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
por: Quatrini, Linda, et al.
Publicado: (2020)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2020)

Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience
por: Kaufman, Stuart S., et al.
Publicado: (2021)

P1311: GRANULOCYTE COLONY-STIMULATING FACTOR MOBILIZATION FACILITATES ANTI-GRAFT-VERSUS-HOST DISEASE AND GRAFT-VERSUS-LEUKEMIA EFFECTS OF MUCOSA-ASSOCIATED INVARIANT T CELLS THROUGH DISTINCT FUNCTIONAL SUBSE
por: Gao, M., et al.
Publicado: (2022)

Psycholinguistic and affective norms for 1,252 Spanish idiomatic expressions
por: Gavilán, José M., et al.
Publicado: (2021)

Small intestinal flora graft alters fecal flora, stool, cytokines and mood status in healthy mice
por: Xie, Yinyin, et al.
Publicado: (2021)

Simultaneous determination of cis- and trans-palmitoleic acid in rat serum by UPLC–MS/MS
por: Huang, Wenwen, et al.
Publicado: (2022)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?
por: Abudayyeh, Ala, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bgib16h9ad39atdu3297btj1ik